Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G/A for Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2024.
Octagon Capital Advisors LP - 31 Dec 2024 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- DNTH
- Shares outstanding
- 29,720,662 shares
- Disclosed Ownership
- 2,110,167 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2025, 17:42:54 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 7.1% ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 17:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 7.1% | 2,110,167 | 0 | 2,110,167 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund LP | 6.1% | 1,818,500 | 0 | 1,818,500 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Octagon Private Opportunities Fund II LP | 1% | 291,667 | 0 | 291,667 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 7.1% | 2,110,167 | 0 | 2,110,167 | /s/ Ting Jia | Ting Jia |